Screening for familial hypercholesterolemia in children: What can we learn from adult screening programs?

Healthcare (Switzerland)

Volumn 3, Issue 4, 2015, Pages 1018-1030

  Henneman, Lidewij ^a   McBride, Colleen M ^b   Cornel, Martina C ^a   Duquette, Debra ^c   Qureshi, Nadeem ^d  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b EMORY UNIVERSITY   (United States)

^c Genomics and Genetic Disorders Section   (United States)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Familial hypercholesterolemia; Genetic testing; Pediatrics; Population screening; Prevention; Public health genomics

Indexed keywords

EID: 84978917863     PISSN: None     EISSN: 22279032     Source Type: Journal    
DOI: 10.3390/healthcare3041018     Document Type: Note

References (55)

1. Rose, G. Sick individuals and sick populations. Int. J. Epidemiol. 1985, 14, 32–38.
2. Evans, J.P.; Berg, J.S.; Olshan, A.F.; Magnuson, T.; Rimer, B.K. We screen newborns, don’t we?: Realizing the promise of public health genomics. Genet. Med. 2013, 15, 332–334.
3. Henneman, L.; van El, C.G.; Cornel, M.C. Genetic testing and implications for personalized medicine: Changes in public and healthcare professional perspectives. Pers. Med. 2013, 10, 217–219.
4. Van El, C.G.; Cornel, M.C. Genetic testing and common disorders in a public health framework. Eur. J. Hum. Genet. 2011, 19, 377–381.
5. Kassner, U.; Wuhle-Demuth, M.; Missala, I.; Humphries, S.E.; Steinhagen-Thiessen, E.; Demuth, I. Clinical utility gene card for: Hyperlipoproteinemia, TYPE II. Eur. J. Hum. Genet. 2014, doi:10.1038/ejhg.2013.271.
6. Nordestgaard, B.G.; Chapman, M.J.; Humphries, S.E.; Ginsberg, H.N.; Masana, L.; Descamps, O.S.; Wiklund, O.; Hegele, R.A.; Raal, F.J.; Defesche, J.C.; et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: Guidance for clinicians to prevent coronary heart disease. Eur. Heart J. 2013, 34, 3478a–3490a.
7. Marks, D.; Thorogood, M.; Neil, H.A.; Humphries, S.E. A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. Atherosclerosis 2003, 168, 1–14.
8. Neil, A.; Cooper, J.; Betteridge, J.; Capps, N.; McDowell, I.; Durrington, P.; Seed, M.; Humphries, S.E. Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: A prospective registry study. Eur. Heart J. 2008, 29, 2625–2633.
9. Versmissen, J.; Oosterveer, D.M.; Yazdanpanah, M.; Defesche, J.C.; Basart, D.C.; Liem, A.H.; Heeringa, J.; Witteman, J.C.; Lansberg, P.J.; Kastelein, J.J.; et al. Efficacy of statins in familial hypercholesterolaemia: A long term cohort study. BMJ 2008, doi:10.1136/bmj.a2423.
10. Williams, R.R.; Hopkins, P.N.; Stephenson, S.; Wu, L.; Hunt, S.C. Primordial prevention of cardiovascular disease through applied genetics. Prev. Med. 1999, 29, S41–S49.
11. World Health Organization. Familial Hypercholesterolemia-Report of a Second WHO Consultation; World Health Organization: Geneva, Switzerland, 1999; Volume 99.
12. DeMott, K.; Nherera, L.; Shaw, E.J.; Minhas, R.; Humphries, S.E.; Kathoria, M.; Ritchie, G.; Nunes, V.; Davies, D.; Lee, P. Clinical Guidelines and Evidence Review for Familial Hypercholesterolaemia: The Identification and Management of Adults and Children with Familial Hypercholesterolaemia; National Collaborating Centre for Primary Care and Royal College of General Practitioners: London, UK, 2008.
13. Kusters, D.M.; de Beaufort, C.; Widhalm, K.; Guardamagna, O.; Bratina, N.; Ose, L.; Wiegman, A. Paediatric screening for hypercholesterolaemia in Europe. Arch. Dis. Child 2012, 97, 272–276.
14. Ritchie, S.K.; Murphy, E.C.; Ice, C.; Cottrell, L.A.; Minor, V.; Elliott, E.; Neal, W. Universal versus targeted blood cholesterol screening among youth: The CARDIAC project. Pediatrics 2010, 126, 260–265.
15. Williams, R.R.; Hunt, S.C.; Barlow, G.K.; Chamberlain, R.M.; Weinberg, A.D.; Cooper, H.P.; Carbonari, J.P.; Gotto, A.M., Jr. Health family trees: A tool for finding and helping young family members of coronary and cancer prone pedigrees in Texas and Utah. Am. J. Public Health 1988, 78, 1283–1286.
16. National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: Summary report. Pediatrics 2011, 128, S213–S256.
17. Wiegman, A.; Gidding, S.S.; Watts, G.F.; Chapman, M.J.; Ginsberg, H.N.; Cuchel, M.; Ose, L.; Averna, M.; Boileau, C.; Borén, J.; et al. Familial hypercholesterolaemia in children and adolescents: Gaining decades of life by optimizing detection and treatment. Eur. Heart J. 2015, 36, 2425–2437.
18. Qureshi, N. Background paper: Summary of WONCA 98 Workshops: Family doctors talk genetics. Eur. J. Gen. Pract. 1999, 5, 33–34.
19. Houwink, E.J.; van Luijk, S.J.; Henneman, L.; van der Vleuten C.; Dinant, G.J.; Cornel, M.C. Genetic educational needs and the role of genetics in primary care: A focus group study with multiple perspectives. BMC Fam. Pract. 2011, doi:10.1186/1471-2296-12-5.
20. Acheson, L.S.; Wiesner, G.L.; Zyzanski, S.J.; Goodwin, M.A.; Stange, K.C. Family history-taking in community family practice: Implications for genetic screening. Genet. Med. 2000, 2, 180–185.
21. Gray, J.; Jaiyeola, A.; Whiting, M.; Modell, M.; Wierzbicki, A.S. Identifying patients with familial hypercholesterolaemia in primary care: An informatics-based approach in one primary care centre. Heart 2008, 94, 754–758.
22. Shugar, A.L. The family history: An integral component of paediatric health assessment. Paediatr. Child Health 2003, 8, 33–35.
23. Therrell, B.L.; Padilla, C.D.; Loeber, J.G.; Kneisser, I.; Saadallah, A.; Borrajo, G.J.; Adams, J. Current status of newborn screening worldwide: 2015. Semin. Perinatol. 2015, 39, 171–187.
24. St. Pierre, J.; Bach, J.; Duquette, D.; Oehlke, K.; Nystrom, R.; Silvey, K.; Zlot, A.; Giles, R.; Johnson, J.; Anders, H.M.; et al. Strategies, actions, and outcomes of pilot state programs in public health genomics, 2003–2008. Prev. Chronic. Dis. 2014, doi:org/10.5888/pcd11.130267.
25. Final Recommendation Statement. BRCA-related Cancer: Risk Assessment, Genetic Counseling and Genetic Testing, December 2013. Available online: http://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing (accessed on 28 August 2015).
26. Evaluation of Genomic Application in Practice and Prevention (EGAPP). Available online: http://www.egappreviews.org/recommendations/lynch.htm (accessed on 28 August 2015).
27. Wilson, J.M.G.; Jungner, G. Principles and Practice of Screening for Disease; World Health Organization: Geneva, Switzerland, 1968; Volume 68.
28. Broekhuizen, K.; van Poppel, M.N.; Koppes, L.L.; Kindt, I.; Brug, J.; van Mechelen, W. Can multiple lifestyle behaviours be improved in people with familial hypercholesterolemia? Results of a parallel randomised controlled trial. PLoS ONE 2012, doi:10.1371/journal.pone.0050032.
29. Marks, D.; Wonderling, D.; Thorogood, M.; Lambert, H.; Humphries, S.E.; Neil, H.A. Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia. BMJ 2002, 324, PMC113765.
30. Vuorio, A.; Kuoppala, J.; Kovanen, P.T.; Humphries, S.E.; Tonstad, S.; Wiegman, A.; Drogari, E. Statins for children with familial hypercholesterolemia. Cochrane. Database. Syst. Rev. 2014, doi:10.1002/14651858.CD006401.pub3.
31. Besseling, J.; Sjouke, B.; Kastelein, J.J. Screening and treatment of familial hypercholesterolemia— Lessons from the past and opportunities for the future (based on the Anitschkow Lecture 2014). Atherosclerosis 2015, 241, 597–606.
32. Talmud, P.J.; Shah, S.; Whittall, R.; Futema, M.; Howard, P.; Cooper, J.A.; Harrison, S.C.; Li, K.; Drenos, F.; Karpe, F.; et al. Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: A case-control study. Lancet 2013, 381, 1293–1301.
33. Taylor, A.; Wang, D.; Patel, K.; Whittall, R.; Wood, G.; Farrer, M.; Neely, R.D.; Fairgrieve, S.; Nair, D.; Barbir, M.; et al. Mutation detection rate and spectrum in familial hypercholesterolaemia patients in the UK pilot cascade project. Clin. Genet. 2010, 77, 572–580.
34. Wald, D.S.; Bestwick, J.P.; Wald, N.J. Child-parent screening for familial hypercholesterolaemia: Screening strategy based on a meta-analysis. BMJ 2007, doi:10.1136/bmj.39300.616076.55.
35. Khoury, M.J.; Evans, J.P. A public health perspective on a national precision medicine cohort: Balancing long-term knowledge generation with early health benefit. JAMA 2015, 313, 2117–2118.
36. Cottrell, L.; John, C.; Murphy, E.; Lilly, C.L.; Ritchie, S.K.; Elliott, E.; Minor, V.; Neal, W.A. Individual-, family-, community-, and policy-level impact of a school-based cardiovascular risk detection screening program for children in underserved, rural areas: The CARDIAC Project. J. Obes. 2013, doi:10.1155/2013/732579.
37. Landelijk Expertisecentrum Erfelijkheidsonderzoek Familiaire Hart-en Vaatziekten (LEEFH). Available online: http://www.leefh.nl (accessed on 22 September 2015).
38. Wald, D.S.; Kasturiratne, A.; Godoy, A.; Ma, L.; Bestwick, J.P.; Brewer, N.; Wald, N.J. Child-parent screening for familial hypercholesterolemia. J. Pediatr. 2011, 159, 865–867.
39. Klančar, G.; Grošelj, U.; Kovač, J.; Bratanič, N.; Bratina, N.; Podkrajšek, K.T.; Battelino, T. Universal Screening for Familial Hypercholesterolemia in Children. J. Am. Coll. Cardiol. 2015, 66, 1250–1257.
40. Lyons, R.; Mickelson, K.; Sullivan, M.; Coyne, J. Coping as a communal process. J. Soc. Pers. Relatsh. 1998, 15, 579–605.
41. Sung-Chan, P.; Sung, Y.W.; Zhao, X.; Brownson, R.C. Family-based models for childhood-obesity intervention: A systematic review of randomized controlled trials. Obes. Rev. 2013, 14, 265–278.
42. Newson, A.J.; Humphries, S.E. Cascade testing in familial hypercholesterolaemia: How should family members be contacted? Eur. J. Hum. Genet. 2005, 13, 401–408.
43. Van Maarle, M.C.; Stouthard, M.E.; Marang-van de Mheen, P.J; Klazinga, N.S.; Bonsel, G.J. How disturbing is it to be approached for a genetic cascade screening programme for familial hypercholesterolaemia? Psychological impact and screenees’ views. Community Genet. 2001, 4, 244–252.
44. Nherera, L.; Marks, D.; Minhas, R.; Thorogood, M.; Humphries, S.E. Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies. Heart 2011, 97, 1175–1181.
45. Umans-Eckenhausen, M.A.; Oort, F.J.; Ferenschild, K.C.; Defesche, J.C.; Kastelein, J.J.; de Haes, J.C. Parental attitude towards genetic testing for familial hypercholesterolaemia in children. J. Med. Genet. 2002, doi:10.1136/jmg.39.9.e49.
46. Rigter, T.; Henneman, L.; Kristoffersson, U.; Hall, A.; Yntema, H.G.; Borry, P.; Tonnies, H.; Waisfisz, Q.; Elting, M.W.; Dondorp, W.J.; et al. Reflecting on earlier experiences with unsolicited findings: Points to consider for next-generation sequencing and informed consent in diagnostics. Hum. Mutat. 2013, 34, 1322–1328.
47. Borry, P.; Evers-Kiebooms, G.; Cornel, M.C.; Clarke, A.; Dierickx, K.; On behalf of the Public and Professional Policy Committee (PPPC) of the European Society of Human Genetics (ESHG). Genetic testing in asymptomatic minors: Background considerations towards ESHG recommendations. Eur. J. Hum. Genet. 2009, 17, 711–719.
48. Committee on Bioethics; Committee on Genetics; The American College of Medical Genetics; Genomics Social, Ethical, Legal Issues Committee. Ethical and policy issues in genetic testing and screening of children. Pediatrics 2013, 131, 620–622.
49. Ross, L.F.; Saal, H.M.; David, K.L.; Anderson, R.R. Technical report: Ethical and policy issues in genetic testing and screening of children. Genet. Med. 2013, 15, 234–245.
50. Rifai, N.; Neufeld, E.; Ahlstrom, P.; Rimm, E.; D’Angelo, L.; Hicks, J.M. Failure of current guidelines for cholesterol screening in urban African-American adolescents. Pediatrics 1996, 98, 383–388.
51. Meulenkamp, T.M.; Tibben, A.; Mollema, E.D.; van Langen, I.M.; Wiegman, A.; de Wert, G.M.; de Beaufort, I.D.; Wilde, A.A.; Smets, E.M. Predictive genetic testing for cardiovascular diseases: Impact on carrier children. Am. J. Med. Genet. A 2008, 146A, 3136–3146.
52. Smets, E.M.; Stam, M.M.; Meulenkamp, T.M.; van Langen, I.M.; Wilde, A.A.; Wiegman, A.; de Wert, G.M.; Tibben, A. Health-related quality of life of children with a positive carrier status for inherited cardiovascular diseases. Am. J. Med. Genet. A 2008, 146A, 700–707.
53. De Jongh, S.; Kerckhoffs, M.C.; Grootenhuis, M.A.; Bakker, H.D.; Heymans, H.S.; Last, B.F. Quality of life, anxiety and concerns among statin-treated children with familial hypercholesterolaemia and their parents. Acta Paediatr. 2003, 92, 1096–1101.
54. Familial Hypercholesterolemia. Available online: http://thefhfoundation.org/about-fh/what-is-fh/(accessed on 25 August 2015).
55. Defesche, J.C. Defining the challenges of FH screening for familial hypercholesterolemia. J. Clin. Lipidol. 2010, 4, 338–341.